Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Algeta and Bayer agree $2.9bn sweetened takeover

This article was originally published in Scrip

Executive Summary

Norway's Algeta has accepted a takeover bid from partner Bayer after the German group increased its offer by nearly 8%. The bid, which will see Bayer assume full control of the developer of its prostate cancer radiopharmaceutical Xofigo (radium-223 dichloride), has been upped to $2.9bn from $2.4bn.


Related Content

Will AAA's Nuclear Med Offerings Turn M&A Buzz Into A Deal?
BIO Notebook, Day 2: Deal Insights, A Payer Perspective And EMA Rumors


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts